IMI suspends work in 4 China factories | Inquirer Business

IMI suspends work in 4 China factories

safety measures mandated amid n-Cov outbreak
By: - Business Features Editor / @philbizwatcher
/ 09:47 AM January 30, 2020

IMI’s facility in Jiaxing, China

Ayala-led electronics manufacturer Integrated Micro-Electronics Inc. (IMI) has suspended operations in four factories in mainland China and halted business trips of its employees to and from high-risk regions amid the outbreak of the Novel Coronavirus (n-CoV).

In a disclosure to the Philippine Stock Exchange on Thursday, IMI said it had delayed resumption of work in selected facilities in China to conform with local government notices regarding n-CoV.

Article continues after this advertisement

The provincial government units concerned, in accordance with the Emergency Response Law and Infectious Disease Prevention and Control Law of the People’s Republic of China, extended the holidays to ensure the implementation of measures and response requirements and further strengthen the control of the n-CoV.

FEATURED STORIES

The IMI manufacturing sites affected by these advisories are located in the following: Pingshan Kuichong, Guandong (IMI Technology Shenzhen Co. Ltd.); Jiaxing, Zhejiang (Speedy-Tech Electronics Jiaxing Co. Ltd.; Chengdu, Sichuan (IMI Chengdu Ltd.); and, Suzhou, Jiangsu (VIA Optronics Suzhou Co. Ltd.).

“IMI is developing contingency plans to recover production backlogs as a result of these suspensions including among others, the temporary transfer of production activities for some customers to other IMI manufacturing plants,” IMI said.

Article continues after this advertisement

“Management is communicating with local government offices regarding the possibility of resuming production earlier than the mandated dates at reduced production capacity,” it said.

Article continues after this advertisement

At the earliest, the Guandong and Zhejiang facilities were estimated to resume on Feb. 10 and Jiangsu facility, on Feb. 9. The Chengdu facility is estimated to resume on Feb. 3, at the earliest.

IMI said it’s implementing guidelines to address and manage employees who manifest symptoms associated with n-Cov.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS:

No tags found for this post.
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.